Cite

HARVARD Citation

    Michaelson, M. et al. (2019). A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors. Oncologist. pp. 1151-e817. [Online]. 
  
Back to record